Delivery Order SPE2DB24D2106-SPE2DB25FAWPV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $31,518.19 to DMS Pharmaceutical Group Inc. for 90 tablets of Jardiance 25 mg, a diabetes medication. The award was issued on August 18, 2025, with an ultimate completion date of August 19, 2025. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $499.9 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on April 24, 2025, for the supply of Jardiance 25 mg tablets (90-count packages). This firm fixed-price delivery order, valued at $10,511.40, is set to be completed by April 25, 2025, and will be performed at the contractor's Park Ridge location. The award carries no set-aside designation, indicating DMS...
- The U.S. Department of Defense's Defense Logistics Agency Troop Support Medical awarded a firm-fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Jardiance 25 mg tablets. The order has a potential value of $4,094.64 and is set to be completed by February 9, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that holds an indefinite delivery contract with the Defense Logistics Agency, valued at...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $7,162.08 to DMS Pharmaceutical Group Inc. for the supply of Jardiance 25 mg tablets (90-count packages). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform delivery to Conshohocken, Pennsylvania by the August 22, 2025 completion date. This delivery order was awarded without set-aside designation and represents a continuation of DMS...
- The Defense Logistics Agency awarded a $17.8K firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jardiance 25 mg tablets (90-count units). The delivery order, issued on April 21, 2025, with an ultimate completion date of April 22, 2025, carries no set-aside designation. This award represents a continuation of DMS Pharmaceutical Group's established role as a critical supplier...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,255.70 by the Defense Logistics Agency (DLA) on April 24, 2025. The contract calls for the supply of Jardiance 10 mg tablets in a 90-count package, with completion scheduled for April 25, 2025. This delivery order was issued without a set-aside designation and is performed at the contractor's facility in Park Ridge,...
- The Defense Logistics Agency awarded a delivery order valued at $4.7 million to DMS Pharmaceutical Group Inc. for 90-count tablets of Jardiance 25 mg, a diabetes medication. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. The contract utilizes a firm fixed-price structure with no set-aside...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, a delivery order valued at $18,413.70 for 90-count tablets of Jardiance 25 mg on August 18, 2025, with a completion date of August 19, 2025. This firm fixed-price delivery order was issued without a set-aside designation and will be performed in Park Ridge, Illinois, where the vendor is headquartered. Jardiance is a prescription medication commonly prescribed for type 2...
- The Defense Logistics Agency awarded a delivery order valued at $30,010.06 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jardiance 10 mg tablets in quantities of 90. The contract employs a firm fixed-price structure with an ultimate completion date of September 12, 2025, and carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract...
- This delivery order, valued at $5,089.90, awards DMS Pharmaceutical Group Inc. a firm fixed-price contract for Jardiance 10 mg tablets (90-count supply) to support Department of Defense medical supply requirements. The order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DB program, valued at $499,999,999 and valid through November 2026. Performance will be executed from the vendor's location in...
- SPE2DB24D2106Indefinite Delivery Contract
- SPE2DB24D2106-SPE2DB25FAWPVDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was awarded a firm fixed-price delivery order valued at $8,512.19 by the Defense Logistics Agency (DLA) on September 19, 2025, for the supply of Jardiance 25 mg tablets in quantities of 90. The delivery order, which carries no set-aside designation, is scheduled for completion by September 22, 2025, with performance to take place in Conshohocken, Pennsylvania. This award represents a discrete delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499,999,999 single-award vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to secure consistent contract awards from the DLA. The company's portfolio demonstrates extensive experience delivering branded and generic prescription drugs, biologics, and medical consumables to military health facilities across the nation. This particular delivery order for Jardiance, a diabetes medication, exemplifies the company's role in providing essential pharmaceutical products that support the medical needs of Department of Defense healthcare systems and beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 9/19/25 |